Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Psilocybin falls into a regulatory gray zone, with strict limitations around how it can be studied. As a result, very little is known about its health risks, despite its surging popularity.
April 09, 2026
Russia can falsify GPS signals deep into Europe, Lithuania says
Iran war dims hopes for German economic recovery, surveys show
Honeywell's Quantinuum targets $12.7 billion valuation in US IPO
Wrong sort of 'boom' to start the week
Knicks fans forget about the bad times and savor a record run to their first NBA Finals since 1999
Estée Lauder exits Puig talks, preserves firepower for selective M&A
Colonial-era New Delhi club ordered to move, sparking debate on India's elites